Reports that the National Institutes of Health Recombinant DNA Advisory Committee are recommending that similar trials involving patients with X-linked, severe combined immunodeficiency syndrome continue to be suspended. Status of gene transfer and gene therapy clinical trials in the U.S.; Advice regarding gene therapy clinical protocols.